ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
174 hedge funds and large institutions have $649M invested in Intercept Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 58 increasing their positions, 52 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
45% less capital invested
Capital invested by funds: $1.18B → $649M (-$529M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
174
Holding in Top 10
1
Calls
$36M
Puts
$47.8M
Top Buyers
| 1 | +$21.3M | |
| 2 | +$11M | |
| 3 | +$8.72M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.63M |
| 5 |
BlackRock
New York
|
+$7.87M |
Top Sellers
| 1 | -$48.8M | |
| 2 | -$32.4M | |
| 3 | -$29.1M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$17.3M |
| 5 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
-$9.19M |